Open AccessStreptococcus agalactiae Toxic Shock-Like Syndrome
Author(s) -
Fadi Al Akhrass,
Lina Abdallah,
Steven C. Berger,
Rami Hanna,
Nina Reynolds,
Shellie Thompson,
Rabih Hallit,
Patrick M. Schlievert
Publication year - 2013
Publication title -
medicine
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0b013e31827dea11
Subject(s) - toxic shock syndrome , streptococcus agalactiae , medicine , streptococcus , shock (circulatory) , mucocutaneous zone , microbiology and biotechnology , mortality rate , intensive care medicine , disease , staphylococcus aureus , bacteria , biology , genetics
We present 2 patients with Streptococcus agalactiae toxic shock-like syndrome and review another 11 well-reported cases from the literature. Streptococcal toxic shock-like syndrome is a devastating illness with a high mortality rate, therefore we stress the importance of early supportive management, antimicrobial therapy, and surgical intervention. Toxic shock-like syndrome is likely to be underestimated in patients with invasive Streptococcus agalactiae infection who present with shock. Early diagnosis requires high suspicion of the illness, along with a thorough mucocutaneous examination. Streptococcus agalactiae produces uncharacterized pyrogenic toxins, which explains the ability of the organism to cause toxic shock-like syndrome.